Literature DB >> 2355190

Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children.

M Arditi1, K R Manogue, M Caplan, R Yogev.   

Abstract

In prospective studies, tumor necrosis factor (TNF alpha) was detected in cerebrospinal fluid (CSF) of 33 of 38 children with bacterial meningitis (BM) but in none of 15 with viral meningitis/encephalitis (P less than .001). BM CSF TNF alpha (less than 35 to greater than 25,500 pg/ml) correlated with CSF bacterial density (P less than .01), CSF protein (P less than .001), endotoxin (LPS) in gram-negative disease (P less than .01), and consecutive febrile hospital days (P less than .001); initial CSF TNF alpha greater than 1000 pg/ml was associated with seizures (P less than .05). Only 5 children with BM (13%) had detectable plasma TNF alpha activity on admission. A higher proportion who died had detectable plasma TNF alpha activity compared with survivors (3/4 vs. 2/34, P less than .005). Platelet-activating factor (PAF) in CSF was higher in 19 children with Haemophilus influenzae meningitis than in 17 controls (P less than .01) and correlated with bacterial density (P less than .01), CSF LPS (P less than .01), CSF TNF alpha levels (P less than .01), and the Herson-Todd severity score (P less than .01). Elevated CSF TNF alpha and PAF are often present in children with BM and are associated with seizures and severity of disease. Detectable CSF TNF alpha appears to distinguish BM from viral meningitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2355190     DOI: 10.1093/infdis/162.1.139

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Systemic inflammation alters the inflammatory response in experimental lipopolysaccharide-induced meningitis.

Authors:  T O'Reilly; C Ostergaard; J Vaxelaire; O Zak
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 3.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.

Authors:  E Svenungsson; M Andersson; L Brundin; R van Vollenhoven; M Khademi; A Tarkowski; D Greitz; M Dahlström; I Lundberg; L Klareskog; T Olsson
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 5.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 6.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

Review 7.  Meningitis.

Authors:  H P Lambert
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

8.  Platelet-activating factor augments meningeal inflammation elicited by Haemophilus influenzae lipooligosaccharide in an animal model of meningitis.

Authors:  G C Townsend; W M Scheld
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Inhibition of endotoxin-induced interleukin 8 release by teicoplanin in human whole blood.

Authors:  A Focà; G Matera; M C Berlinghieri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

10.  Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence.

Authors:  M Bonnet; P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.